To date, there are limited data and little consensus on treatment strategies for huge hepatocellular carcinoma (HCC). Surgical resection provides significantly better survival than other modalities for single large HCC regardless of tumor stage. Recently, with technological advances in radiation therapy, stereotactic body radiation therapy (SBRT) is considered an alternative treatment option for HCC. Herein, we present a case of huge HCC that was successfully managed by SBRT. Transarterial embolization, previously performed in Russia, was incomplete. It was also not suitable for resection and transarterial chemoembolization. Although the rationale for radiotherapy in huge HCC was insufficient, SBRT was performed because no other treatment options were available. Additional radiofrequency ablation was performed for small HCC in a different segment, and radiological complete response (CR) was achieved. The CR was maintained over 4 years. Therefore, SBRT may be an alternative treatment option for large HCC that is not suitable for curative treatment.
External beam radiotherapy, transarterial chemoembolization and sorafenib are currently
standard treatments for advanced hepatocellular carcinoma (HCC) with portal vein
thrombosis. However, hepatic arterial infusion chemotherapy has been applied to advanced
stage HCC with a view to improving the therapeutic effect. We experienced a case of
advanced HCC with clinical complete response after hepatic artery infusion chemotherapy
and radiation therapy and report that.
Citations
Citations to this article as recorded by
A Case of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Treated by Hepatic Arterial Infusion Chemotherapy and Radiotherapy Jin Yong Lee, Jeong-Ju Yoo, Seong Joon Chun, Sun Hyun Bae, Jae Myeong Lee, Sang Gyune Kim, Young Seok Kim Journal of Liver Cancer.2020; 20(1): 78. CrossRef
Recently, various combination therapies have been applied to the treatment of hepatocellular
carcinoma (HCC). Among various treatment modalities, transarterial chemoembolization
(TACE) and radiofrequency ablation (RFA) were combined to improve the therapeutic effect of
RFA. The decrease of blood flow by TACE can increase the size of the ablation area by reducing
heat loss during RFA. Based on these theoretical advantages, TACE and RFA combination
therapy have been tried for the treatment of patients with HCC which is not feasible to be
removed by surgery. However, TACE and RFA combination therapy has not been standardized
by various protocols for each study. This review discusses the implications and role of this
treatment, although there are several limitations to clearly demonstrate the indications and
efficacy of TACE and RFA combination therapies.
Hepatocellular carcinoma (HCC) have relatively well known causative factors such as chronic
hepatitis B, chronic hepatitis C, alcoholic liver disease, Non-alcoholic fatty liver disease (NAFLD),
liver cirrhosis and so on. Recently, interesting reports that HCC in the absence of cirrhosis
or other chronic liver disease and HCC associated with NAFLD and metabolic syndrome are
increasing in USA. So far, there is no report about these issues in Korea. We present a 65 yearold
obesity male who had no preceding chronic liver disease history. He was diagnosed as
primary HCC and the mass was removed completely. However, HCC recurred shortly after
operation. Multiple recurred HCC were treated with transcatheter arterial chemoembolization.
(J Liver Cancer 2015;15:112-117)
Kyung In Lee, Young Lan Kwon, Yoon Jung Kim, Hye Jin Seo, Yong Jin Kim, Chang Wook Park, Eun Soo Kim, Byoung Kuk Jang, Woo Jin Chung, Kyung Sik Park, Kwang Bum Cho, Jae Seok Hwang, Jung Hyeok Kwon
Journal of the Korean Liver Cancer Study Group. 2010;10(1):64-68. Published online June 30, 2010
Bone metastasis is not uncommon and shows poor survival in patients with hepatocellular carcinoma (HCC). We describe
a case of HCC presenting with rib metastasis in a 54-year-old man. In spite of radiotherapy for rib metastasis, pain was
sustained and size of lesions were increased. So we performd CT-guided percutaneous ethanol injection therapy (PEIT).
Whenever new metastatic bone lesions were detected, we have done PEIT. However, abdominal CT scan at 25th month after
diagnosis shows residual viable tumors in pelvic bone and multiple metastatic nodules in both lung. He is alive by taking
conservative management for 27 months after diagnosis.
Advanced hepatocellular carcinoma (HCC) with portal vein thrombosis is not suitable candidates for surgical treatment at
the most of diagnosis because of poor liver function, extensive tumor involvement of the liver, vascular involvement, and/or
intra/extrahepatic metastasis. We attempted localized concurrent chemo-radiation therapy (CCRT) in patients having locally
advanced HCC with left and main portal vein thrombosis. We report a case of locally advanced HCC patient who became
surgically resectable by downstaging after localized CCRT. Localized CCRT was performed with a total radiation dose of
5,040 cGy (180 cGy×28 times) and hepatic arterial infusion of 5-fluorouracil (5-FU, 250 mg/day) and cisplatin (10 mg/day)
for 5 days via implantable port system during the second and the fifth weeks of the radiotherapy. Marked contraction of HCC
was noted on follow up computerized tomography (CT) after localized CCRT, and subsequently surgical resection with
curative aim was performed. He was gave a additional transcatheter arterial chemoembolization (TACE) because follow up
CT revealed intrahepatic metastasis at subcapsular portion of right hepatic lobe after 3 months of operation. The patient is
in complete remission status without recurrence to date.
Improved imaging techniques have led to increasing detection of hepatic nodules incidentally. In many cases, a
lesion that has been detected by imaging studies is not sufficiently characteristic, or there are other clinical
concern, so that an imaging guided percutaneous needle biopsy is performed for definitive diagnosis. But
sometimes, there are diagnostic difficulty due to limited diagnostic samples. We report a case of diagnosis to
benign nodule, but not confirmed specific disease, by repeated CT guided fine needle biopsy.
Prognosis of advanced hepatocellular carcinoma (HCC) treated by conventional therapies has been considered
to be poor. Hepatic arterial infusion therapy (HAIT) has been tried for advanced hepatocellular carcinoma with
portal vein tumor thrombosis or ineffective response to other treatment. We report two cases of advanced HCC
showing good respense to transarterial chemoembolization and CT guided percutaneous ethanol injection therapy.
Extrahepatic metastases of hepatocellular carcinoma (HCC) are now increasing due to prolonged survival.
Extrahepatic metastases of HCC frequently develop in patients with more advanced stage and sometimes occur
without intrahepatic recurrence. We report two cases bone metastasis of HCC without intrahepatic recurrence
after treatment.
A 52-year-old man who underwent left hepatectomy with lymph node dissection due to hepatocellular carcinoma with lymph node metastasis. After 5 months of surgery, multiple recurrences were founded throughout the liver, lung, bones and intraperitoneal lymph nodes. The patient died of liver failure after rupture of recurrent hepatic tumor. From our experience, we reaffirmed that the prognosis of patients with nodal metastasis from hepatocellular carcinoma was generally poor, even after hepatic resection with lymph node dissection was performed.